Skip to main content
logo
Bionano Genomics, Inc. (BNGO)
NASDAQ: BNGO · Real-Time Price · USD
1.200
+0.010 (0.84%)
At close: Aug 12, 2026, 4:00 PM EDT
1.207
+0.007 (0.56%)
After-hours: Aug 12, 2026, 4:54 PM EDT

Bionano Genomics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-16.45-26.4-112.02-232.49-132.6-72.44
Depreciation & Amortization
4.829.7314.2313.919.843.37
Stock-Based Compensation
1.874.539.7415.1822.429.72
Other Adjustments
0.41-4.7314.9892.993.46-4.93
Change in Receivables
-1.7-0.454.14-2.3-2.25-0.49
Changes in Inventories
3.084.92-0.59-4.15-23.68-15.93
Changes in Accounts Payable
-0.65-1.37-3.42-21.956.78
Changes in Accrued Expenses
1.24-0.58-2.24-2.520.373.96
Changes in Other Operating Activities
-2.71-26.26-3.81-4.33-1.97
Operating Cash Flow
-10.1-16.35-68.92-125.18-124.82-71.93
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
---0.1-1.69-3.2-1.46
Sale of Property, Plant & Equipment
----0.03-
Purchases of Intangible Assets
-----0.1-
Purchases of Investments
-125.32-241.88-233.02-111.26-84.2-313.39
Proceeds from Sale of Investments
124.68229.13306.96137.02200.8986.48
Cash Acquisitions
-----31.34-49.09
Proceeds from Business Divestments
---0.10.69-
Other Investing Activities
------0.61
Investing Cash Flow
-0.64-12.7573.8424.1682.77-278.06

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
--16.2575.48--
Long-Term Debt Repaid
-1.92-4.95-71.43-9.05-0.04-15.01
Net Long-Term Debt Issued (Repaid)
-1.92-4.95-55.1866.43-0.04-15.01
Issuance of Common Stock
13.5928.9941.556.3823.04351.12
Net Common Stock Issued (Repurchased)
13.5928.9941.556.3823.04351.12
Other Financing Activities
----9--
Financing Cash Flow
11.6724.04-13.69113.8223.01336.11

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
0.02-0.01-0.010.07-0.04-
Net Cash Flow
0.95-5.06-8.7812.86-19.08-13.88

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-10.1-16.35-69.03-126.87-128.02-73.39
Free Cash Flow Growth
------
FCF Margin
-65.90%-57.33%-224.28%-351.29%-460.46%-408.14%
Free Cash Flow Per Share
-1.06-3.00-54.31-222.97-265.58-159.09
Levered Free Cash Flow
-12.6-20.65-153.06-166.31-151.68-92.69
Unlevered Free Cash Flow
-11.36-22.73-89.87-215.56-152.64-76.71
SEC Filings: 10-K · 10-Q